Skip to main content
Clinical Trials/NCT05456230
NCT05456230
Completed
Not Applicable

Comparison of Postoperative Delirium in Elders Anaesthetised With Midazolam and Without Midazolam During Non-cardiac Surgery

Chinese PLA General Hospital1 site in 1 country11,927 target enrollmentApril 1, 2020
InterventionsMidazolam

Overview

Phase
Not Applicable
Intervention
Midazolam
Conditions
Postoperative Delirium
Sponsor
Chinese PLA General Hospital
Enrollment
11927
Locations
1
Primary Endpoint
Incidence of postoperative delirium
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This research project is an observational cohort study by prospective chart review of patients that underwent surgery in multi-centers, China, in the years 2020-2022. The purpose of this study is to compare the occurrence of postoperative delirium With Midazolam and Without Midazolam During Non-cardiac Surgery in Elders.

Detailed Description

Post operative delirium will be diagnosed using the 3D- CAM(Confusion Assessment Method) which tests for four features with a series of questions. The features include 1) acute onset and fluctuating course,2) inattention,3) disorganized thinking and 4) altered level of consciousness. Diagnosis of delirium is made if features 1 and 2 and either 3 or 4 are present. The demographic data of the patients,type and site of surgery will be noted. Preoperative hemoglobin, serum electrolytes and blood urea will be recorded. The intraoperative factors like duration of surgery and anaesthesia,use of intravenous fluids ,blood loss, number blood units transfused and opioid use will be studied at the time of surgery. The time to emergence and extubation following the completion of surgery will be noted. The postoperative factors like postoperative pain, nausea and vomiting, fever,hemoglobin,serum electrolytes and blood urea will be noted. Preoperative and postoperative pain will be assessed using the numerical rating score on a scale of one to ten. The association of various preoperative,intraoperative and postoperative factors with POD will be determined.

Registry
clinicaltrials.gov
Start Date
April 1, 2020
End Date
July 11, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chinese PLA General Hospital
Responsible Party
Principal Investigator
Principal Investigator

Weidong Mi

Director (Cheif expert of National key research and development program of China 2018YFC2001900)

Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • Geriatric surgical patients ≥65 years old Underwent elective non-cardiac surgery

Exclusion Criteria

  • History of neuropsychiatric diseases including delirium, mental disorders, Parkinson, dementia, etc.; The operation was cancelled due to various reasons after the patient was enrolled; severe liver disease; severe renal dysfunction defined as either having creatinine clearance \< 30 ml/min or being dialysis-dependent; Patients who undergo second operation in a short period; Refused to participate in the study.

Arms & Interventions

Midazolam

Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.

Intervention: Midazolam

Outcomes

Primary Outcomes

Incidence of postoperative delirium

Time Frame: Day 7 postoperatively

Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily

Secondary Outcomes

  • the incidence of survival rate(1 year)

Study Sites (1)

Loading locations...

Similar Trials